<DOC>
	<DOC>NCT01255423</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy of Diclofenac Sodium Topical (DSG) 1% compared with placebo applied four times a day in subjects with acute ankle sprains under 'in-use' conditions, in particular with regard to pain relief.</brief_summary>
	<brief_title>Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied 4 Times Daily in Subjects With Acute Ankle Sprain</brief_title>
	<detailed_description />
	<mesh_term>Ankle Injuries</mesh_term>
	<mesh_term>Sprains and Strains</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Inclusion criteria: 1. Male or female aged 18 years and over. 2. Acute sprain of the lateral ankle, Grade III, meeting baseline pain intensity level. 3. Injury within past 12 hours. Exclusion criteria: 1. Pain medication was taken within the 6 hours that precede randomization. 2. During the past 3 months: Grade IIII sprain of the same ankle. 3. During the past 6 months: Grade IIIII sprain, any other significant injury (such as fracture or torn ligament), or surgery (except for skin or nails) of the same ankle or foot. 4. Pain or instability in the same ankle attributable to previous ankle sprain or any other trauma. 5. Ankle sprain attributable to a known disease affecting the ligaments, such as ligament hyperlaxity due to connective tissue disease (e.g., Marfan's syndrome, Down's syndrome, EhlersDanlos syndrome). Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Ankle sprain, soft tissue injury</keyword>
</DOC>